Chemed (CHE) reported Q4 adjusted earnings late Wednesday of $6.83 per diluted share, up from $6.60 a year earlier.

Three analysts surveyed by FactSet expected $6.78.

Revenue for the quarter ended Dec. 31 was $640 million, up from $585.9 million a year earlier.

Three analysts polled by FactSet expected $636.1 million.

The company expects full-year 2025 adjusted EPS of $24.95 to $25.45.

Three analysts surveyed by FactSet expect $24.89.